180 related articles for article (PubMed ID: 27876749)
1. Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin.
Cavalcante CS; Falcão CB; Fontenelle RO; Andreu D; Rádis-Baptista G
J Antibiot (Tokyo); 2017 Mar; 70(3):231-237. PubMed ID: 27876749
[TBL] [Abstract][Full Text] [Related]
2. The antiproliferative peptide Ctn[15-34] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans.
de Aguiar FLL; Cavalcante CSDP; Dos Santos Fontenelle RO; Falcão CB; Andreu D; Rádis-Baptista G
J Appl Microbiol; 2020 Feb; 128(2):414-425. PubMed ID: 31626724
[TBL] [Abstract][Full Text] [Related]
3. Insights into the candidacidal mechanism of Ctn[15-34] - a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins.
Cavalcante CSP; de Aguiar FLL; Fontenelle ROS; de Menezes RRPPB; Martins AMC; Falcão CB; Andreu D; Rádis-Baptista G
J Med Microbiol; 2018 Jan; 67(1):129-138. PubMed ID: 29214974
[TBL] [Abstract][Full Text] [Related]
4. Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity.
Falcao CB; Pérez-Peinado C; de la Torre BG; Mayol X; Zamora-Carreras H; Jiménez MÁ; Rádis-Baptista G; Andreu D
J Med Chem; 2015 Nov; 58(21):8553-63. PubMed ID: 26465972
[TBL] [Abstract][Full Text] [Related]
5. The Rhodamine B-encrypted Vipericidin Peptide, RhoB-Ctn[1-9], Displays In vitro Antimicrobial Activity Against Opportunistic Bacteria and Yeasts.
Lima HVD; Dos Santos TMC; de Sousa Silva MMA; da Silva Albuquerque JV; Melo LM; de Figueirêdo Freitas VJ; Rádis-Baptista G
Curr Pharm Biotechnol; 2022; 23(2):172-179. PubMed ID: 33749557
[TBL] [Abstract][Full Text] [Related]
6. Antibiofilm Activity on
Aguiar FLL; Santos NC; de Paula Cavalcante CS; Andreu D; Baptista GR; Gonçalves S
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172206
[TBL] [Abstract][Full Text] [Related]
7. Antichagasic effect of crotalicidin, a cathelicidin-like vipericidin, found in Crotalus durissus terrificus rattlesnake's venom gland.
Bandeira ICJ; Bandeira-Lima D; Mello CP; Pereira TP; De Menezes RRPPB; Sampaio TL; Falcão CB; Rádis-Baptista G; Martins AMC
Parasitology; 2018 Jul; 145(8):1059-1064. PubMed ID: 29208061
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom.
Pérez-Peinado C; Dias SA; Domingues MM; Benfield AH; Freire JM; Rádis-Baptista G; Gaspar D; Castanho MARB; Craik DJ; Henriques ST; Veiga AS; Andreu D
J Biol Chem; 2018 Feb; 293(5):1536-1549. PubMed ID: 29255091
[TBL] [Abstract][Full Text] [Related]
9. The anti-infective crotalicidin peptide analog RhoB-Ctn[1-9] is harmless to bovine oocytes and able to induce parthenogenesis in vitro.
Santos ATD; Kumar S; Albuquerque JVDS; Arcce IML; Chaves OA; Cruz GS; Carretero VJ; Melo LM; Chaves MS; Guijo JMH; Freitas VJF; Rádis-Baptista G
Toxicon; 2023 Oct; 234():107274. PubMed ID: 37657514
[TBL] [Abstract][Full Text] [Related]
10. The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.
Tajbakhsh M; Karimi A; Tohidpour A; Abbasi N; Fallah F; Akhavan MM
J Microbiol; 2018 Feb; 56(2):128-137. PubMed ID: 29392557
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants conferring unusual long life in human serum to rattlesnake-derived antimicrobial peptide Ctn[15-34].
Pérez-Peinado C; Dias SA; Mendonça DA; Castanho MARB; Veiga AS; Andreu D
J Pept Sci; 2019 Aug; 25(8):e3195. PubMed ID: 31317613
[TBL] [Abstract][Full Text] [Related]
12. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
[TBL] [Abstract][Full Text] [Related]
13. Crotamine and crotalicidin, membrane active peptides from Crotalus durissus terrificus rattlesnake venom, and their structurally-minimized fragments for applications in medicine and biotechnology.
Falcao CB; Radis-Baptista G
Peptides; 2020 Apr; 126():170234. PubMed ID: 31857106
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
[TBL] [Abstract][Full Text] [Related]
15. Parallel evaluation of antimicrobial peptides derived from the synthetic PAF26 and the human LL37.
López-García B; Ubhayasekera W; Gallo RL; Marcos JF
Biochem Biophys Res Commun; 2007 Apr; 356(1):107-13. PubMed ID: 17336936
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds.
van Eijk M; Boerefijn S; Cen L; Rosa M; Morren MJH; van der Ent CK; Kraak B; Dijksterhuis J; Valdes ID; Haagsman HP; de Cock H
Med Mycol; 2020 Nov; 58(8):1073-1084. PubMed ID: 32236485
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
Wildfeuer A; Seidl HP; Paule I; Haberreiter A
Arzneimittelforschung; 1997 Nov; 47(11):1257-63. PubMed ID: 9428984
[TBL] [Abstract][Full Text] [Related]
18. Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates.
Tavanti A; Maisetta G; Del Gaudio G; Petruzzelli R; Sanguinetti M; Batoni G; Senesi S
Peptides; 2011 Dec; 32(12):2484-7. PubMed ID: 22015266
[TBL] [Abstract][Full Text] [Related]
19. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts.
Benincasa M; Scocchi M; Pacor S; Tossi A; Nobili D; Basaglia G; Busetti M; Gennaro R
J Antimicrob Chemother; 2006 Nov; 58(5):950-9. PubMed ID: 17023499
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.
De Brucker K; Delattin N; Robijns S; Steenackers H; Verstraeten N; Landuyt B; Luyten W; Schoofs L; Dovgan B; Fröhlich M; Michiels J; Vanderleyden J; Cammue BP; Thevissen K
Antimicrob Agents Chemother; 2014 Sep; 58(9):5395-404. PubMed ID: 24982087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
